Morphic Medical

GI Dynamics is Now Morphic Medical. Learn More.

Weight Reduction and Improvement in Diabetes by the Duodenal-Jejunal Bypass Liner: a 198 Patient Cohort Study

Treatment with the DJBL in T2DM patients with (morbid) obesity results in improvement in glucose control, a reduction in anti-diabetic medication, and significant weight loss. The largest changes are observed within the first 3-6 months. Initial C-peptide levels and body weight may help to select patients with the greatest chance of success.


How RESET Works

Maintenance of Efficacy After RESET

BBC News Item

DJBL for the Treatment of Type 2 Diabetes and Obesity: EASD 2022